RNA is the new DNA. The dynamic nature, diversity and abundance in both tissues and biofluids makes it an excellent source for assessing health status and treating disease. We believe that unraveling both coding and non-coding RNA will lead to biomarkers and RNA targeting therapies for better healthcare.
Through excellence in science and technology, we wish to deploy the human transcriptome for rational development of next generation RNA diagnostics and therapeutics in oncology.
Biogazelle is a biotechnology company built on a culture of providing high quality science based on the core values of passion, courage, collaboration and open communication.